Diamondback Energy is posting one of its better weeks of the summer, up nearly 6% to $211.53, yet the most telling signal this week is not the price action — it is the steady stream of insider sales flowing against it.
The insider story is the week's central tension. In the 90 days through September 11, insiders net-sold more than 218,000 shares worth roughly $43 million, with zero open-market purchases to offset. The names and roles make this notable: CEO Matthew Kaes Van't Hof sold 10,000 shares across two tranches on August 20, collecting over $2.1 million. COO Daniel Wesson sold 7,500 shares the same day for another $1.6 million. Former CEO Travis Stice — now a director — sold 75,000 shares on September 11 for more than $15.3 million. None of these trades were flagged as pre-arranged 10b5-1 plan sales, which makes them more discretionary in nature. The cluster of C-suite and board-level selling into a rising tape is the kind of signal that at minimum warrants attention.
Short interest provides little additional drama either way. Bears are not piling in with conviction: short interest runs at 2.8% of the free float, up roughly 14% on the week but still sitting at levels that barely register as meaningful pressure. The lending market is extremely loose — availability has climbed to 8,835%, meaning there are roughly 88 shares available to borrow for every one currently borrowed, deep inside the "plenty of supply" range. Cost to borrow doubled over the week to 0.47%, which sounds dramatic in percentage terms but in absolute terms remains a trivially cheap level for a Permian large-cap. The ORTEX short score sits at 37.6, little changed across the past ten sessions. Nothing in the positioning data suggests shorts are building a meaningful thesis against this stock.
Options traders are similarly relaxed. The put/call ratio is running at 0.70, essentially flat against its 20-day average of 0.70, with a z-score near zero — in other words, options positioning is as neutral as it gets. Neither side is loading up on directional bets ahead of the next print. That earnings date, for context, is November 2, and the prior two quarterly results produced immediate day-one declines of 5-6%, though the five-day window was more mixed. That pattern, when it comes into view again, is worth holding in mind.
The Street is generally constructive but has been quietly trimming expectations. UBS analyst Josh Silverstein raised his target to $253 from $243 on September 14, maintaining his Buy — the most recent action. But that follows a Morgan Stanley downgrade to Equal-Weight in late August, with a $216 target that is almost exactly where the stock was trading at the time. Barclays trimmed its Overweight target from $232 to $221 in the same period. The consensus mean target sits at $234, implying around 11% upside from current levels — respectable but not wide enough to suggest the Street sees this as deeply mispriced. Valuation multiples are modest for a large-cap E&P: the stock trades at roughly 10.7x earnings and 6.3x EV/EBITDA, with forward EPS growth ranking in the 83rd percentile across the ORTEX universe. The bull case rests on Permian scale, lowest-quartile costs, and free cash flow conversion. The bear case centres on well productivity risk and commodity price sensitivity — standard E&P variables, nothing idiosyncratic.
One register worth monitoring is the activist 13D filing from SGF FANG Holdings, LP, which carries a 26.3% stake and has been reducing its position — down from 29.9% at the prior disclosure — through five amendments since initially filing in August 2025. That matches the "Lyndal Greth" institutional holder in the ownership data holding 74 million shares, pointing to the same vehicle. A structured seller of that size unwinding into market strength is a different kind of overhead supply than the typical insider sale. As always with Schedule 13D/G disclosures, the stake is as-last-reported around the 5% threshold, and further reductions may not trigger an immediate filing obligation. The pace and direction of that unwind — alongside whether the CEO and his colleagues continue selling on any further rally — is what to watch into the November earnings window.
See the live data behind this article on ORTEX.
Open FANG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
